A Parsonage-Turner Syndrome secondary to Parvovirus B19 infection
Main Article Content
Keywords
Parvovirus B19, Parsonage-Turner Syndrome
Abstract
Parvovirus B19 (PVB19) is a small DNA virus that causes the fifth disease in children; however it can also affect adults. The infection can be asymptomatic in about a quarter of healthy subjects. Typical clinical manifestations are: short lived fever accompanied by asthenia, myalgias and pharyngodynia; symmetrical acute polyarthritis; megalo-erytema in child; maculopulotic rash and/or fleeting purpuric at the extremities in adult; adenopathies in the cervical area. Atypical manifestions can affect neurological system (both central and peripheral), hearth and kidney. We describe a 37-year-old man with neuralgic amyotrophy (Parsonage-Turner syndrome) caused by Parvovirus B19 infection.
Downloads
References
[2] Bultmann BD, Klingel K, Sotlar K, Bock T, Kandolf R, Parvovirus B19: a pathogen responsible for more than hematologic disorders Virchows Arch 2003;442:8-17
[3] Modrow S, Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris 2002; 50:326-31
[4] Labau E, Bonnet E, Alric L, Massip P, Infection par le Parvovirus B19 Nouvelles approches phsiopathologiques. Presse Med 1996; 25:162-6
[5] Karmochkine M, Infection humaine par le Parvovirus B19. Rev Mèd Interne 1995; 16:905-12
[6] Hayakawa H, Tara M, Niina K, Osame M. A clinical study of adult human parvovirus B19 infection. Intern Med 2002; 41:259-9
[7] Kerr JR, Coyle PV, DeLeys RJ, Patterson CC. Follow-up study of clinical and immulogical findings in patients presenting with acute Parvovirus B19 infection,
J Med Virol 1996; 48:68-75
[8] Woolf AD,Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, et al Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989; 149: 1153-6
[9] Oiwa H, Shimada T,Hashimoto M, Kawaguchi A, Ueda T, Sugiyama E, et al. Clinical findings in parvovirus B19 infection in 30 adult patients in Kyoto. Mod Rheumatol 2011; 21:24-31
[10] Waza K, Inoue K, Matsumura S, Symptoms associated with parvovirus B19 infection in adults: a pilot study Intern Med 2007; 46:1975-8
[11] Varache S, Narbonne V, Jousse-Joulin S, Guennoc X, Dougados M, Daurès JP, et al Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Result from a nationwide longitudinal prospective cohort study Arthritis Care Res 2011; 63: 1565-70
[12] Moore TL. Parvovirus-associated arthritis. Curr Opinion Rheumatol 2000; 12: 289-94
[13] Vassilopoulos D, Calabrese LH. Viraly associated arthritis: clinical epidemiologic and pathophysiologic considerations Arthritis Res Ther 2008 ; 10:215.
[14] Hashimoto H, Yuno T. Parvovirus B19-associated purpuric-petechial eruption J Clin Virol 2011; 52: 268-71
[15] Douvoyiannis M, Litman N, Goldman DL. Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis 2009; 48:1713-23
[16] Lenglet T, Haroche J, Schnuriger A, Maisonobe T, Viala K, Michel Y, et al Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome. J Neurol 2011; 258:1321-6
[17] Scheibe F, Hofmann J, Ruprecht K, Parainfectious myelitis associated with parvovirus B19infection. J Neurol 2010; 257:1557-8
[18] Rabar D, Peyramond D. Dysesthèsies prolongèes rèvèlant une primo-infection à Parvovirus B19. Med Mal Infect 2005; 35: 91-4
[19] Le Scanff J, Vighetto A, Mekki Y, Nguyen AM, Dufour JF, Broussolle C, et al. Acute ophthalmoparesis associated with human parvovirus B19 infection. Eur J Ophthalmol 2010;20: 802-4
[20] Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur Heart J 2008;29:2073-82
[21] Trochu JN, Piriou N, Toquet C, Bressollette C, Valleix F, Le Tourneau T, et al. Myocardites. Rev Med Interne 2012; 33: 567-74
[22] Basic D, Gupta S, Kwong RY. Parvovirus B19-induceded myocarditis mimicking acute myocardial infarction: clarification of diagnosis by cardiac magnetic resonance imaging. Circulation 2010;121: 40-2
[23] Bock CT,Klingel K, Kandolf R. Human parvovirus B19-associated myocarditis. N Engl J Med 2010;362: 1248-9
[24] Stewart GC, Lopez-Molina J, Gottumukkala RVSRK, Rosner GF, Anello MS, Hecht JL, et al. Myocardial parvovirus B19 persistence: lack of association with clinico-pathologic phenotype in adults with heart failure. Circ Heart Fail 2011;4:71-8
[25] Waldman M, Kopp JB. Parvovirus B19 and the Kidney. Clin Jam Soc Nephhrol 2007 ;2 (suppl 1):47-56
[26] Magy L. Neuropathies pèripheriques: dèmarche diagnostique. La Revue de mèdicine interne 39(2018) 27-33
[27] Parsonage MJ, Turner AJW. Neuralgic amyotrophy, the shoulder girdle syndrome.Lancet 1948; 254 : 973-8
[28] Van Alfen N, Van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006; 129: 438-50
[29] Van Alfen N, Van Eijk jj, Ennik t, et al. Incidence of neuralgic amyotrophy(Parsonage-Turner syndrome) in a primary care setting-a prospective cohort study. Plos One 2015; 10: eO128361
[30] MacDonald BK, Cockerell OC, Sander JW et al. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123:665-76
[31] Cruz-Martinez A, Barrio M, Arpa J. Neuralgic amyotrophy:variable expression in 40 patients. J Peripher Nerv Syst 2002; 7: 198-204
[32] Denning DW, Amos A, Rudge P, Cohen BJ. Neuralgic amyotrophy due to parvovirus infection, J Neurol Neurosurg Psychiatry, 1987, vol.50 641-2
[33] Walsh KJ, Amstrong RD,Turner AM. Brachial plexus neuropathy associated with human parvovirus infection, Br Med J Clin ReS Ed, 1988 vol 296 896
[34] Faden H, Gary GWJr, Anderson LJ. Chronic parvovirus infection in a presumably immunologically healthy woman, Clin Infect Dis, 1992, vol15 595-7
[35] Maas JJ, Beersma MF, Haan J, Jonkers GJ, Kroes AC. Bilateral brachial plexus neuritis following parvovirus B19 and cytomegalovirus infection, Ann Neurol, 1996, vol 40 928-32
[36] Puechal X, Hilliquin P, Kahan A, Menkes CJ. Neuralgic amyotrophy and polyarthritis caused by parvovirus B19 infection, Ann Rheum Dis , 1998 57, 262
[37] Van Alfen N, Huisman WJ, Overeem S, et al. Sensory nerve conduction studies in neuralgic amyotrophy. Am J Phys Med Rehabil 2009;88: 941-6
[38] Beghi E, Kurland LT, Mulder DW, et al. Brachial plexus neuropathy in the population of Rochester. Minnesota 1970-1981. Ann Neurol 1985; 18: 320-3
[39] Winer JB, Hughes RA, Anderson MJ, et al. A prospective study of acute idiopathic neuropatthy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1998;51:613-8
[40] Pham M,Baumer P, Meinck HM, et al. Anterior interosseus nerve syndrome fascicular motor lesions of median nerve trunk. Neurology 2014; 82:598-606
[41] Gaskin CM, Helms CA. Parsonage-Turner syndrome: MR imaging findings and clinical information of 27 patients. Radiology 2006; 240:501-7
[42] Pan Y, Wang S, Zheng D, et al. Hourglass-like constrictions of peripheral nerve in the upper extremity: a clical review anda pathological study. Neurosurgery 2014; 75:10-22
[43] Van Eijk JJ, Van Allen N, Berrevoets M, et al. Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study . J Neurol Neurosurg Psychiatry 2009;80:1120-4
[44] Johnson NE, Petraglia AL, Huang JH et al. Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids anda intravenous immunoglobulin. Muscle Nerve 2011;44: 304-5
[45] Naito KS, Fukushima K, Suzuki S et al. Intravenous immunoglobulin (IVg)with methylprednisolone pulse therapy for motor impairment of neuralgic amyotrophy:clinical observations in 10 cases. Intern Med 2012;26: 841-4
Article Sidebar
Article Details
How to Cite
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Flavio Mozzani, Azienda Ospedaliero-Universitaria di Parma
Department of Medicine, Internal Medicine and Rheumatology Unit
Noemi Giuliana Marino, Azienda Ospedaliero-Universitaria di Parma
Department of Medicine, Internal Medicine and Rheumatology Unit
Andrea Becciolini, Azienda Ospedaliero-Universitaria di Parma
Department of Medicine, Internal Medicine and Rheumatology Unit
Eleonora Di Donato, Azienda Ospedaliero-Universitaria di Parma
Department of Medicine, Internal Medicine and Rheumatology Unit
Alarico Ariani, Azienda Ospedaliero-Universitaria di Parma
Department of Medicine, Internal Medicine and Rheumatology Unit
Daniele Santilli, Azienda Ospedaliero-Universitaria di Parma
Department of Medicine, Internal Medicine and Rheumatology Unit